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ABSTRACT
Marine-derived actinomycetes possess distinct and complex metabolic capabilities,
resulting in the wide diversity of their secondary metabolites in terms of chemical
structure and biological activity. The bioactive compounds of actinomycetes isolated
from mangrove soils are reported to possess various biological activities such as
antimicrobial, cytotoxicity, anticancer and antioxidant. The aims of this study are to
isolate and characterize diverse populations of marine actinomycetes from mangrove
soils, to identify selected morphologically distinct isolates by using 16S rRNA
sequence analysis, to screen their potential biological activities as antimicrobial as
well as p-lactamase inhibitor agents, and to elucidate the structure of selected
bioactive compounds. A total of 73 actinomycete strains were isolated from II
mangrove locations in Malaysia. Of these, morphological observations and 16S rRNA
sequence analys is indicate the presence of representative species from at least 3
genera Streptomyces, Pseudonocardia and Saccharomonospora. The majority of the
isolates belong to genus Streptomyces. It was found that the most productive medium
for isolation is starch casein nitrate agar (SCNA). It was also found that addition of
3% sodium chloride (NaCl) improved the isolation rate of mangrove actinomycetes.
Disc diffusion assay showed that 9.6% (direct broth culture) and 8.2% (ethyl acetate
extract) of these isolates were able to produce antimicrobial compounds active against
Staphylococcus aureus, Bacillus subtilis, Candida albicans as well as Saccharomyces
cerevisiae. Hexane extracts however exhibited no activity. A modified microdilution
plate assay showed that 16.4% (ethyl acetate extract) of these strains were able to
generate antimicrobial compounds active against Staphylococcus aureus, Bacillus
subtilis, Escherichia coli and Candida albicans. A rapid screening assay for P-
lactamase inhibitors activity by resazurin microdilution plate assay was developed and
showed that 4.9% of actinomycete isolates were able to produce inhibitor compounds
against Staphylococcus aureus ATCC 43300. The KMS I isolate was chosen as a lead
candidate because this strain showed consistent production of antimicrobial and
inhibitor active compounds throughout the screening experiments. Nuclear magnetic
resonance (NMR) spectroscopy analysis showed that the active compound (KMS 1-
2B) was 4-hydroxybenzoic acid.
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CHAPTER ONE
INTRODUCTION
1.1 BACKGROUND OF STUDY
Actinomycetes are filam entous and sporulating Gram-positive bacteria
characterized by a complex life cycle belonging to the phylum Actinobacteria.
Actinobacteria are widely distributed in both terrestrial and aquatic ecosystems
mainly soil. They are known as degrader and also as decomposer because they recycle
the nutrients associated with intractable polymers such as chitin, keratin and
lignocelluloses in soil biodegradation and humus formation (Sharma, 2014; Stach and
Bull , 2005 ; McCarthy and Williams, 1992; Goodfellow and Williams, 1983) . These
activities resulted in the production of volatile substances like geosmin which is
responsible for the 'wet earth odour' characteristic (Wilkins, 1996) and exhibited
diverse physiolo gical and metabolic prop erties, for example the manufacture of
extracellular enzyme s (Schrempf, 200 I; McCarthy and Williams, 1992). They are all
reported to have high guanine and cytosine content in their DNA and identified as the
most economically and biotechnologically valuable bacteria that provide many
important bioactive compounds (Gulve and Deshmukh, 2012).
Natural products are chemical compounds originated from living organisms
such as plants, animals as well as microorganisms. They are known to be the most
consistently successful source of drug leads. Traditionally, higher plants used to be
the most productive sources of drugs from nature (Ginsburg and Deharo, 20 II) and
the uses of medicinal plants are well reported (Pan et aI., 2014). Microorganisms
heralded the era of natural products after the discovery of penicillin in 1929 by Sir
Alexander Fleming and started to be used clinically in the 1940s (Pela ez, 2006). Since
then , the discov ery of antibiotics from microbes has been intensively studied. After a
few decades, the discovery of secondary metabolites from microorganisms has been
slowly decreased. The researchers started to focus on synthesizing existing
compounds. However, due to the increase in resistance to current antibiotics and other
antimicrobial compounds (Spizek et aI., 20 I0), the search of new compounds
particularly from microorganisms is regaining favour among scien tists.
